Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by ledrogon Jun 10, 2018 7:54pm
250 Views
Post# 28152355

Not meaning to confuse, or spread doom and gloom....

Not meaning to confuse, or spread doom and gloom....I share the opinion of most here....that with success on the BETonMACE trial, that Resverlogix will be headed to a multi billion dollar valuation.  And when you consider the "Cascade" mentioned in the Beacon Report by Dr. Kideckle I see serious potential for that to be just the start....after Diabetes comes potential in CKD and Fabry's, then Alzheimers, FHSD, Thrombosis, Friedrich's Ataxia....HIV as recently PR'd. 

Who knows what a drug like Apabetalone just on its own could be worth?  Now add in the epiegnetic blood bank that Resverlogix has developed and the potential for a pipeline that could target cancers and a host of other diseases.  

The potentail boggles the mind....I think Apabetalone alone could be worth 10s of billions if its able to treat a multitude of diseases and conditions, maybe even 100s of billions.

I have stated the opinion already, that with positive Top Line results from BETonMACE, that RVX could be trading at about $10 by the end of the year...and that if that does come to pass I would likely let a few thousand shares go.  But I genuniely believe that could be just the start....How high could RVX go in the years to come if the things play out...$30, $50....I genuinely think $100+ is not out of the question.

If that's doom and gloom???  Well, then....bring it on. 

It is precisely because of my opinion that I expect shorts to hammer the stock tomorrow.  I do not think I am the only one with this incredibly bullish view, I believe there are other parties who see the same potential who want in badly....and that they'll go to extreme lengths to demoralize shareholders in the hopes that they'll cut and run.....because, no matter what a stock is trading at, you can't buy shares unless there are others willing to sell shares.

So again, I am expecting a short attack tomorrow....but if I am right its not a reason to be scrared or worried about doom and gloom imo....i believe it will be a HUGE buying opportunity.
Bullboard Posts